Clinical Trials
37 trialsMVX-ONCO-2 in Advanced Solid Tumors
University Hospital, Geneva
ImmuCCo
Centre Oscar Lambret
Okgyn1
University of Oklahoma
Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
Masonic Cancer Center, University of Minnesota
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Samsung Medical Center
CTC-CEC-ADN
Institut Curie
PACPAC-EPOC
Center Eugene Marquis
MEDIPAC
National University Hospital, Singapore
Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1
Tomsk National Research Medical Center of the Russian Academy of Sciences
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Tianjin Medical University Second Hospital
CASTLE-11
Fudan University
NeoTIL in Advanced Solid Tumors
Centre Hospitalier Universitaire Vaudois
MoST-TAP
Omico
SprayDye
Erasmus Medical Center
Anti-cancer DC Cell Vaccination to Treat Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period
Peking University First Hospital
RACIN
Centre Hospitalier Universitaire Vaudois
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
Georgetown University
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils
Wuxi People's Hospital
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Baptist Health South Florida
Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors
Affiliated Hospital of Jiangnan University
TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital
IMPRESS
Royal Marsden NHS Foundation Trust
Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors
Wuxi No. 4 People's Hospital
Safety Study of 89Zr-NY001 PET Imaging in Patients
Wuxi No. 4 People's Hospital
89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors
Wuxi No. 4 People's Hospital
Yoga for Solid Tumor
Abramson Cancer Center at Penn Medicine
K-BASKET, TAS-117, PI3K/AKT Gene Aberration
Yonsei University
Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors
Centre Hospitalier Universitaire Vaudois
A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer
Kyunghee University Medical Center
CPV2-0
Institut Paoli-Calmettes
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Soochow University
Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors
Chinese PLA General Hospital
RESIL
University of Lausanne